LifeStance Health Group’s (LFST) “Outperform” Rating Reiterated at William Blair

LifeStance Health Group (NASDAQ:LFST)‘s stock had its “outperform” rating reaffirmed by William Blair in a note issued to investors on Friday,RTT News reports. William Blair also issued estimates for LifeStance Health Group’s Q1 2025 earnings at ($0.03) EPS, Q2 2025 earnings at ($0.03) EPS, Q3 2025 earnings at ($0.02) EPS, Q4 2025 earnings at ($0.02) EPS and FY2025 earnings at ($0.10) EPS.

A number of other analysts have also recently weighed in on LFST. Barclays boosted their target price on shares of LifeStance Health Group from $6.00 to $7.00 and gave the stock an “underweight” rating in a research note on Monday, November 11th. The Goldman Sachs Group upgraded shares of LifeStance Health Group from a “neutral” rating to a “buy” rating and set a $10.00 price target on the stock in a report on Monday, December 16th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, LifeStance Health Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $8.70.

LifeStance Health Group Stock Performance

NASDAQ LFST opened at $7.79 on Friday. The firm’s fifty day moving average price is $7.80 and its two-hundred day moving average price is $7.23. The stock has a market cap of $2.98 billion, a PE ratio of -29.96 and a beta of 1.28. LifeStance Health Group has a fifty-two week low of $4.64 and a fifty-two week high of $9.00. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.32 and a current ratio of 1.32.

Hedge Funds Weigh In On LifeStance Health Group

A number of hedge funds have recently modified their holdings of the business. Vanguard Group Inc. lifted its holdings in shares of LifeStance Health Group by 7.9% during the fourth quarter. Vanguard Group Inc. now owns 10,689,396 shares of the company’s stock worth $78,781,000 after purchasing an additional 784,818 shares during the period. Jennison Associates LLC lifted its holdings in LifeStance Health Group by 278.4% in the fourth quarter. Jennison Associates LLC now owns 8,086,380 shares of the company’s stock valued at $59,597,000 after buying an additional 5,949,438 shares during the period. Wellington Management Group LLP lifted its holdings in LifeStance Health Group by 9.2% in the fourth quarter. Wellington Management Group LLP now owns 5,276,237 shares of the company’s stock valued at $38,886,000 after buying an additional 445,796 shares during the period. Principal Financial Group Inc. lifted its holdings in LifeStance Health Group by 6.1% in the third quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company’s stock valued at $28,817,000 after buying an additional 235,316 shares during the period. Finally, Dimensional Fund Advisors LP lifted its holdings in LifeStance Health Group by 87.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company’s stock valued at $25,977,000 after buying an additional 1,643,390 shares during the period. Institutional investors and hedge funds own 85.50% of the company’s stock.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.